Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

A black-box warning for antidepressants in children?

Newman TB.

N Engl J Med. 2004 Oct 14;351(16):1595-8. No abstract available.

PMID:
15483275
2.

[The psychopharmacological treatment of depressive disorders in childhood and adolescence - developments and standards since the «black box» warning].

Plener PL, Fegert JM, Kölch MG.

Z Kinder Jugendpsychiatr Psychother. 2012 Nov;40(6):365-71. doi: 10.1024/1422-4917/a000196. Review. German.

PMID:
23109125
4.

Antidepressants & suicide: putting the risk in perspective.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2007 Jul;45(7):15-9. Review.

PMID:
17679311
5.

Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.

Madhusoodanan S, Alexeenko L, Sanders R, Brenner R.

Ann Clin Psychiatry. 2010 Aug;22(3):148-56. Review.

PMID:
20680187
6.

[Medical treatment of depression in children and adolescents].

Kölch M, Fegert JM.

Prax Kinderpsychol Kinderpsychiatr. 2007;56(3):224-33. Review. German.

PMID:
17451152
7.

Selective serotonin reuptake inhibitors and the risk for suicidality in adolescents: an update.

Giner L, Nichols CM, Zalsman G, Oquendo MA.

Int J Adolesc Med Health. 2005 Jul-Sep;17(3):211-20. Review.

PMID:
16231472
8.

Suicide prevention and serotonergic drugs.

Montgomery SA.

Int Clin Psychopharmacol. 1993 Nov;8 Suppl 2:83-5. Review.

PMID:
8201249
9.

Depression, antidepressants and suicidality: a critical appraisal.

Licinio J, Wong ML.

Nat Rev Drug Discov. 2005 Feb;4(2):165-71. Review.

PMID:
15688079
10.

The treatment of adolescent depression in the era of the black box warning.

Richmond TK, Rosen DS.

Curr Opin Pediatr. 2005 Aug;17(4):466-72. Review.

PMID:
16012257
11.

[Antidepressant agents in the therapy of severe depression in adolescents].

Marttunen M, Aalberg V.

Duodecim. 1999;115(1):36-44. Review. Finnish. No abstract available.

PMID:
11830858
12.

Serotonergic mechanisms and the new antidepressants.

Stahl SM.

Psychol Med. 1993 May;23(2):281-5. Review. No abstract available.

PMID:
8332642
13.

Pharmacotherapy of depressed children and adolescents: current issues and potential directions.

Vasa RA, Carlino AR, Pine DS.

Biol Psychiatry. 2006 Jun 1;59(11):1021-8. Epub 2006 Jan 10. Review.

PMID:
16406250
14.

Treatment of major depression in adolescents: weighing the evidence of risk and benefit in light of black box warnings.

Lovrin M.

J Child Adolesc Psychiatr Nurs. 2009 May;22(2):63-8. doi: 10.1111/j.1744-6171.2009.00174.x. Review.

PMID:
19490276
15.

Recognizing depression in children.

Murphy K.

Nurse Pract. 2004 Sep;29(9):18-29; quiz 30-1. Review. No abstract available.

PMID:
15359137
16.

Review of the efficacy and safety of antidepressants in youth depression.

Cheung AH, Emslie GJ, Mayes TL.

J Child Psychol Psychiatry. 2005 Jul;46(7):735-54. Review.

PMID:
15972068
17.

[Antidepressants and suicide in adolescents].

Silva M, Sampaio D.

Acta Med Port. 2011 Jul-Aug;24(4):603-12. Epub 2011 Dec 12. Review. Portuguese.

18.

Are antidepressants safe for adolescents?

Winters NC.

Postgrad Med. 2005 Sep;118(3):33-4. Review. No abstract available.

PMID:
16201306
19.

An update on antidepressant use and suicidality in pediatric depression.

Adegbite-Adeniyi C, Gron B, Rowles BM, Demeter CA, Findling RL.

Expert Opin Pharmacother. 2012 Oct;13(15):2119-30. doi: 10.1517/14656566.2012.726613. Review.

PMID:
22984934
20.

Pharmacological treatment of children and adolescents with depression.

Vitiello B, Ordóñez AE.

Expert Opin Pharmacother. 2016 Dec;17(17):2273-2279. Epub 2016 Oct 14. Review.

PMID:
27690663

Supplemental Content

Support Center